Cargando…
COVID-19 vaccine safety
In response to the SARS-CoV-2 outbreak, and the resulting COVID-19 pandemic, a global competition to develop an anti-COVID-19 vaccine has ensued. The targeted time frame for initial vaccine deployment is late 2020. The present article examines whether short-term, mid-term, and long-term vaccine safe...
Autores principales: | Kostoff, Ronald N., Briggs, Michael B., Porter, Alan L., Spandidos, Demetrios A., Tsatsakis, Aristidis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521561/ https://www.ncbi.nlm.nih.gov/pubmed/33000193 http://dx.doi.org/10.3892/ijmm.2020.4733 |
Ejemplares similares
-
COVID-19: Post-lockdown guidelines
por: Kostoff, Ronald N., et al.
Publicado: (2020) -
Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety
por: Kostoff, Ronald N., et al.
Publicado: (2020) -
Contributing factors common to COVID-19 and gastrointestinal cancer
por: Kostoff, Ronald Neil, et al.
Publicado: (2022) -
The under-reported role of toxic substance exposures in the COVID-19 pandemic
por: Kostoff, Ronald N., et al.
Publicado: (2020) -
Why are we vaccinating children against COVID-19?
por: Kostoff, Ronald N., et al.
Publicado: (2021)